Yazar "Yiğiner, Ömer" için listeleme
-
The effects of supraphysiological oestrogen levels on ventricular repolarisation parameters
Yiğiner, Ömer; Doğan, Mehmet; Gün, İsmet; Kutlu, Hüseyin Tayfun; Değirmencioğlu, Gökhan; Güliyev, İlkin; Tokatlı, Alptuğ; Kılıçaslan, Fethi (Via Medica, 2018)Background: The frequency of arrhythmic death developing without a structural cardiac disease is higher in women. Also, female sex is an independent risk factor regarding development of torsades de pointes. Several studies ... -
Paroxysmal atrial fibrillation and related thromboembolism may be a hidden factor in the development of dementia
Tokatlı, Alptuğ; Yiğiner, Ömer; Özmen, Namık; Uzun, Mehmet; Kılıçaslan, Fethi (Wiley, 2016)We read the article entitled ‘Correlations between homocysteine and grey matter volume in patients with Alzheimer's disease’ by Park et al. with great interest.1 In this well‐designed research, they used brain magnetic ... -
Prolonged Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in patients with Type 2 diabetes mellitus
Tokatlı, Alptuğ; Kılıçaslan, Fethi; Alış, Metin; Yiğiner, Ömer; Uzun, Mehmet (Korean Endocrine Soc, 2016)Background: Type 2 diabetes mellitus (T2DM) is associated \vith increased risk of malignant ventricular arrhythmias. Cardiac electrical inhomogeneity may be the leading cause of the increased arrhythmic risk in patients ... -
Quantification of atrial electrical heterogeneity via atrial electromechanical coupling
Tokatlı, Alptuğ; Yiğiner, Ömer; Kılıçaslan, Fethi; Uzun, Mehmet (Edizioni Minerva Medica, 2017)… -
A real-world, retrospective, observational study of dabigatran and rivaroxaban in Turkey: Elderly patients receive inappropriately low dose of rivaroxaban
Yiğiner, Ömer; Tezcan, Mehmet; Erdal, Emrah; Değirmencioğlu, Gökhan; Acar, Gürkan; Ergelen, Mehmet; Çay, Serkan; Çetin, Hande; Özçelik, Fatih; Doğan, Mehmet; Tokatlı, Alptuğ; Özmen, Namık; Uz, Ömer; Kılıçaslan, Fethi (E-Century Publishing Corp, 2017)Thromboembolic complications are the most important outcomes of atrial fibrillation (AF). New oral anticoagulants (NOACs) have been presented to protect non-valvular AF patients from thromboembolic complications. In this ...